Search

Savitha M. Rao

Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1614, 1621, 1691, 4131
Total Applications
1525
Issued Applications
872
Pending Applications
108
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7126937 [patent_doc_number] => 20050058681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Odorless insect repellant and method of use' [patent_app_type] => utility [patent_app_number] => 10/930863 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1872 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058681.pdf [firstpage_image] =>[orig_patent_app_number] => 10930863 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/930863
Odorless insect repellant and method of use Aug 31, 2004 Abandoned
Array ( [id] => 4927927 [patent_doc_number] => 20080167290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Combination of a Serotonin Reuptake Inhibitor and Amoxapine' [patent_app_type] => utility [patent_app_number] => 10/569346 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167290.pdf [firstpage_image] =>[orig_patent_app_number] => 10569346 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569346
Combination of a Serotonin Reuptake Inhibitor and Amoxapine Aug 31, 2004 Abandoned
Array ( [id] => 5689031 [patent_doc_number] => 20060287346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer' [patent_app_type] => utility [patent_app_number] => 10/570335 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4807 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287346.pdf [firstpage_image] =>[orig_patent_app_number] => 10570335 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570335
Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer Aug 30, 2004 Abandoned
Array ( [id] => 4927986 [patent_doc_number] => 20080167349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Pharmaceutical Product For Injection' [patent_app_type] => utility [patent_app_number] => 10/568417 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4331 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167349.pdf [firstpage_image] =>[orig_patent_app_number] => 10568417 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/568417
Pharmaceutical Product For Injection Aug 18, 2004 Abandoned
Array ( [id] => 5241714 [patent_doc_number] => 20070020206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Use of biotin or a biotin derivative for lightening skin and treating age spots' [patent_app_type] => utility [patent_app_number] => 10/569784 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4164 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020206.pdf [firstpage_image] =>[orig_patent_app_number] => 10569784 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569784
Use of biotin or a biotin derivative for lightening skin and treating age spots Aug 11, 2004 Abandoned
Array ( [id] => 5194427 [patent_doc_number] => 20070082911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Novel use of quinolone antibiotics' [patent_app_type] => utility [patent_app_number] => 10/567057 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3278 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082911.pdf [firstpage_image] =>[orig_patent_app_number] => 10567057 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/567057
Use of quinolone antibiotics Aug 1, 2004 Issued
Array ( [id] => 4880434 [patent_doc_number] => 20080153817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Treatment for Alzheimer\'s Disease and Related Conditions' [patent_app_type] => utility [patent_app_number] => 10/566844 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19841 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153817.pdf [firstpage_image] =>[orig_patent_app_number] => 10566844 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566844
Treatment for Alzheimer's Disease and Related Conditions Jul 28, 2004 Abandoned
Array ( [id] => 7555529 [patent_doc_number] => 08067430 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-11-29 [patent_title] => 'Anti-HIV activity of the opioid antagonist naloxone' [patent_app_type] => utility [patent_app_number] => 10/902471 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3374 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067430.pdf [firstpage_image] =>[orig_patent_app_number] => 10902471 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/902471
Anti-HIV activity of the opioid antagonist naloxone Jul 28, 2004 Issued
Array ( [id] => 5310869 [patent_doc_number] => 20090018150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => '5-Ht2b Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 10/564010 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32609 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018150.pdf [firstpage_image] =>[orig_patent_app_number] => 10564010 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564010
5-Ht2b Receptor Antagonists Jul 22, 2004 Abandoned
Array ( [id] => 5677442 [patent_doc_number] => 20060182797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Sutained release formulation for venlafaxine hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/565322 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7507 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182797.pdf [firstpage_image] =>[orig_patent_app_number] => 10565322 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/565322
Sutained release formulation for venlafaxine hydrochloride Jul 22, 2004 Abandoned
Array ( [id] => 5101815 [patent_doc_number] => 20070185077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Methods of treating, preventing and inhibiting cancer metastasis and tumor formation' [patent_app_type] => utility [patent_app_number] => 10/564945 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19657 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185077.pdf [firstpage_image] =>[orig_patent_app_number] => 10564945 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564945
Methods of treating, preventing and inhibiting cancer metastasis and tumor formation Jul 14, 2004 Abandoned
Array ( [id] => 5677436 [patent_doc_number] => 20060182791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Transdermaltherapeutic system containing a pramipexol active agent' [patent_app_type] => utility [patent_app_number] => 10/564932 [patent_app_country] => US [patent_app_date] => 2004-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3165 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182791.pdf [firstpage_image] =>[orig_patent_app_number] => 10564932 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564932
Transdermaltherapeutic system containing a pramipexol active agent Jul 13, 2004 Abandoned
Array ( [id] => 5875373 [patent_doc_number] => 20060167027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability' [patent_app_type] => utility [patent_app_number] => 10/563668 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5888 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167027.pdf [firstpage_image] =>[orig_patent_app_number] => 10563668 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/563668
Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability Jul 6, 2004 Abandoned
Array ( [id] => 8675540 [patent_doc_number] => 08383653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'SIR2 regulation' [patent_app_type] => utility [patent_app_number] => 10/560676 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13483 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10560676 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/560676
SIR2 regulation Jun 29, 2004 Issued
Array ( [id] => 5672986 [patent_doc_number] => 20060178341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev)' [patent_app_type] => utility [patent_app_number] => 10/561714 [patent_app_country] => US [patent_app_date] => 2004-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6723 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178341.pdf [firstpage_image] =>[orig_patent_app_number] => 10561714 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/561714
Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev) Jun 22, 2004 Abandoned
Array ( [id] => 5045577 [patent_doc_number] => 20070264250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Composition for Skin-Whitening and Wrinkle-Care' [patent_app_type] => utility [patent_app_number] => 11/658136 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4570 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264250.pdf [firstpage_image] =>[orig_patent_app_number] => 11658136 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658136
Composition for Skin-Whitening and Wrinkle-Care Jun 9, 2004 Abandoned
Array ( [id] => 5034277 [patent_doc_number] => 20070098816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Pharmaceutical composition containing histone deacetylase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/558208 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6885 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098816.pdf [firstpage_image] =>[orig_patent_app_number] => 10558208 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558208
Pharmaceutical composition containing histone deacetylase inhibitor May 25, 2004 Abandoned
Array ( [id] => 5000450 [patent_doc_number] => 20070043084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => '1,2-Diarylimidazoles useful as inhibitors of cox' [patent_app_type] => utility [patent_app_number] => 10/555656 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18066 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043084.pdf [firstpage_image] =>[orig_patent_app_number] => 10555656 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555656
1,2-Diarylimidazoles useful as inhibitors of cox Apr 25, 2004 Abandoned
Array ( [id] => 4728175 [patent_doc_number] => 20080207719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Treatment of Epilepsy' [patent_app_type] => utility [patent_app_number] => 10/552892 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1935 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207719.pdf [firstpage_image] =>[orig_patent_app_number] => 10552892 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/552892
Treatment of Epilepsy Apr 7, 2004 Abandoned
Array ( [id] => 7593130 [patent_doc_number] => 07652071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Penetration of active substances into cells and organs' [patent_app_type] => utility [patent_app_number] => 10/551882 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7661 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/652/07652071.pdf [firstpage_image] =>[orig_patent_app_number] => 10551882 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551882
Penetration of active substances into cells and organs Mar 24, 2004 Issued
Menu